The FDA has approved Onapgo, the first subcutaneous apomorphine device to treat motor fluctuations in adults with Parkinson’s disease, according to the manufacturer.In a press release, Supernus ...
Scientists from DZNE, University Hospital Bonn (UKB) and the University of Bonn provide new evidence that preventing brain inflammation is a promising approach for the treatment of Alzheimer's disease ...
The finding may open a whole new world in the study of Alzheimer's disease, said biophysicist Aneta Stefanovska.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback